Bambusa Therapeutics is a rapidly growing biotechnology company specializing in developing transformative inflammatory and immunological therapeutics.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/09/24 | $5,000,000 | Seed |
BVF Partners Dawn Biopharma INCE Capital Salvia | undisclosed |
| 02/14/25 | $90,000,000 | Series A |
ADAR1 Partners BVF Partners Dawn Biopharma INCE Capital Invus Janus Henderson Investors RA Capital Management Redmile Group Salvia | undisclosed |
